Munaza L. Ahmed
Great Ormond Street Hospital NHS Foundation Trust
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Germline duplication of MYCN predisposes to childhood embryonal tumours.
Journal: EBioMedicine
Published: June 05, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACE.
Journal: Breast cancer research : BCR
Published: February 05, 2025
Decision making for health-related research outcomes that alter diagnosis: A model from paediatric brain tumours.
Journal: Neuropathology and applied neurobiology
Published: May 10, 2024
Benefits for children with suspected cancer from routine whole-genome sequencing.
Journal: Nature medicine
Published: November 20, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: April 29, 2023
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 16, 2022
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 30, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.
Journal: Journal of medical genetics
Published: August 26, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.
Journal: Journal of medical genetics
Published: June 07, 2022
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
Journal: Diagnostics (Basel, Switzerland)
Published: March 25, 2022
Last Updated: 09/26/2026